NCT07201402View on ClinicalTrials.gov

Long Term Evaluation of Scapular-inserted Contraceptive Implants

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Contraception
Interventions
DRUG

Scapular-site insertion of etonogestrel contraceptive implant

Participants will undergo insertion of the etonogestrel contraceptive implant subdermally over the inferior edge of their non-dominant scapula

Trial Locations (2)

80045

University of Colorado Anschutz Medical Campus, Aurora

06520

Yale University School of Medicine, New Haven

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Yale University

OTHER